Philip Campbell

The need for a global effort to attend to human neural organoid and assembloid research

Sergiu P. Pașca, Paola Arlotta, Philip Campbell, Alta Charo et autres

us, br, au, de, it (code pays fourni par la source)

The Roles and Responsibilities of Scientific Journals in Research Governance: Editorial Policymaking at Nature and Springer Nature (1995–2023)

Philip Campbell

gb (code pays fourni par la source)

Effect of Correcting Iron Deficiency on the Risk of Serious Infection in Heart Failure: Insights from the IRONMAN Trial

Paul Foley, Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et autres

gb, us (code pays fourni par la source)

142 The impact of ferric derisomaltose in people with heart failure with or without ischaemic heart disease in the ironman trial

Andrew Ludman, John G.F. Cleland, Ian Ford, Fraser J Graham et autres

gb (code pays fourni par la source)

Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial

John G.F. Cleland, Philip A. Kalra, Pierpaolo Pellicori, Fraser J Graham et autres

gb (code pays fourni par la source)

The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction

Robin Ray, Ian Ford, John G.F. Cleland, Fraser J Graham et autres

gb (code pays fourni par la source)

Acalabrutinib Versus Investigator’s Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results

Paolo Ghia, Andrzej Pluta, Małgorzata Wach, Daniel Lysák et autres

it, pl, cz, ua, hu, es, ca, au, gb, us, kr (code pays fourni par la source)

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie, Elizabeth Thomson et autres

gb (code pays fourni par la source)

OAB-048: An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study

Masa Lasica, Andrew Spencer, Philip Campbell, Nicole Wong Doo et autres

The PINK1—Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cells

Aaron Bradshaw, Philip Campbell, Huw R. Morris

Erratum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment” Kidney Int. 2020;97:1287–1296

Éric Rondeau, Marie Scully, Gema Ariceta, Spero Cataland et autres

Modernising the Mental Health Act: getting the balance right

Gerard Lynch, Philip Campbell, Catherine Taggart

gb (code pays fourni par la source)